Sensus Healthcare, Inc. Available-for-sale Securities, Gross Unrealized Gain
Sensus Healthcare, Inc. (SRTS) reported Available-for-sale Securities, Gross Unrealized Gain of $404 for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2020-08-10
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2020-06-30 was -$2.90K, a 357.42% decline year-over-year.
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2020-03-31 was $3.30K, a 169.17% increase year-over-year.
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2019-12-31 was -$841.00.
- Sensus Healthcare, Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2019-09-30 was $4.04K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|---|---|---|
| 2020-06-30 | -$2.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $404.00 10-Q · filed 2020-08-10 | -$437.00 derived: sum of 3 quarters · filed 2020-08-10 | $3.61K derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | $3.30K 10-Q · filed 2020-05-11 | $2.46K derived: sum of 2 quarters · filed 2020-08-10 | $6.50K derived: sum of 3 quarters · filed 2020-08-10 | $7.63K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-12-31 | -$841.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2020-08-10 | $3.20K derived: sum of 2 quarters · filed 2020-08-10 | $4.33K derived: sum of 3 quarters · filed 2020-08-10 | $5.55K 10-Q · filed 2020-08-10 |
| 2019-09-30 | $4.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $5.17K derived: sum of 2 quarters · filed 2019-11-08 | $6.39K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $2.35K 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $1.23K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |